Cargando…

The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants

BACKGROUND: Dysferlinopathy is an autosomal recessive muscular dystrophy caused by pathogenic variants in the dysferlin (DYSF) gene. This disease shows heterogeneous clinical phenotypes and genetic characteristics. METHODS: We reviewed the clinical and pathological data as well as the molecular char...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ning, Han, Xu, Hao, Shengpu, Han, Jingzhe, Zhou, Xiaomeng, Sun, Shuyan, Tang, Jin, Lu, Yanpeng, Wu, Hongran, Ma, Shaojuan, Song, Xueqin, Ji, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623978/
https://www.ncbi.nlm.nih.gov/pubmed/36319958
http://dx.doi.org/10.1186/s12883-022-02905-w
_version_ 1784822128290299904
author Wang, Ning
Han, Xu
Hao, Shengpu
Han, Jingzhe
Zhou, Xiaomeng
Sun, Shuyan
Tang, Jin
Lu, Yanpeng
Wu, Hongran
Ma, Shaojuan
Song, Xueqin
Ji, Guang
author_facet Wang, Ning
Han, Xu
Hao, Shengpu
Han, Jingzhe
Zhou, Xiaomeng
Sun, Shuyan
Tang, Jin
Lu, Yanpeng
Wu, Hongran
Ma, Shaojuan
Song, Xueqin
Ji, Guang
author_sort Wang, Ning
collection PubMed
description BACKGROUND: Dysferlinopathy is an autosomal recessive muscular dystrophy caused by pathogenic variants in the dysferlin (DYSF) gene. This disease shows heterogeneous clinical phenotypes and genetic characteristics. METHODS: We reviewed the clinical and pathological data as well as the molecular characteristics of 26 Chinese patients with dysferlinopathy screened by immunohistochemistry staining and pathogenic variants in DYSF genes. RESULTS: Among 26 patients with dysferlinopathy, 18 patients (69.2%) presented as Limb-girdle Muscular Dystrophy Type R2 (LGMD R2), 4 (15.4%) had a phenotype of Miyoshi myopathy (MM), and 4 (15.4%) presented as asymptomatic hyperCKemia. Fifteen patients (57.7%) were originally misdiagnosed as inflammatory myopathy or other diseases. Fifteen novel variants were identified among the 40 variant sites identified in this cohort. CONCLUSION: Dysferlinopathy is a clinically and genetically heterogeneous group of disorders with various phenotypes, a high proportion of novel variants, and a high rate of misdiagnosis before immunohistochemistry staining and genetic analysis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-022-02905-w.
format Online
Article
Text
id pubmed-9623978
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96239782022-11-02 The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants Wang, Ning Han, Xu Hao, Shengpu Han, Jingzhe Zhou, Xiaomeng Sun, Shuyan Tang, Jin Lu, Yanpeng Wu, Hongran Ma, Shaojuan Song, Xueqin Ji, Guang BMC Neurol Research BACKGROUND: Dysferlinopathy is an autosomal recessive muscular dystrophy caused by pathogenic variants in the dysferlin (DYSF) gene. This disease shows heterogeneous clinical phenotypes and genetic characteristics. METHODS: We reviewed the clinical and pathological data as well as the molecular characteristics of 26 Chinese patients with dysferlinopathy screened by immunohistochemistry staining and pathogenic variants in DYSF genes. RESULTS: Among 26 patients with dysferlinopathy, 18 patients (69.2%) presented as Limb-girdle Muscular Dystrophy Type R2 (LGMD R2), 4 (15.4%) had a phenotype of Miyoshi myopathy (MM), and 4 (15.4%) presented as asymptomatic hyperCKemia. Fifteen patients (57.7%) were originally misdiagnosed as inflammatory myopathy or other diseases. Fifteen novel variants were identified among the 40 variant sites identified in this cohort. CONCLUSION: Dysferlinopathy is a clinically and genetically heterogeneous group of disorders with various phenotypes, a high proportion of novel variants, and a high rate of misdiagnosis before immunohistochemistry staining and genetic analysis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-022-02905-w. BioMed Central 2022-11-01 /pmc/articles/PMC9623978/ /pubmed/36319958 http://dx.doi.org/10.1186/s12883-022-02905-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Ning
Han, Xu
Hao, Shengpu
Han, Jingzhe
Zhou, Xiaomeng
Sun, Shuyan
Tang, Jin
Lu, Yanpeng
Wu, Hongran
Ma, Shaojuan
Song, Xueqin
Ji, Guang
The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants
title The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants
title_full The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants
title_fullStr The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants
title_full_unstemmed The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants
title_short The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants
title_sort clinical, myopathological, and molecular characteristics of 26 chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623978/
https://www.ncbi.nlm.nih.gov/pubmed/36319958
http://dx.doi.org/10.1186/s12883-022-02905-w
work_keys_str_mv AT wangning theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT hanxu theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT haoshengpu theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT hanjingzhe theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT zhouxiaomeng theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT sunshuyan theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT tangjin theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT luyanpeng theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT wuhongran theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT mashaojuan theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT songxueqin theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT jiguang theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT wangning clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT hanxu clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT haoshengpu clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT hanjingzhe clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT zhouxiaomeng clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT sunshuyan clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT tangjin clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT luyanpeng clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT wuhongran clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT mashaojuan clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT songxueqin clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants
AT jiguang clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants